Ortho vision reagents for bdaach korea

Ended Awarded Last action

Contract number
W81K0225FA113
Awardee
Awarding agency
Obligated
$147,760

Award facts

Contract value 100% obligated
$147,759.58 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
South Korea

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Funding Only Action P00002 $147,760
Other Administrative Action P00001 $0
Original award $0

About this award

The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on October 1, 2025, with a ceiling value of $147,759.58 for ortho vision reagents for Bdaach Korea. The order is firm fixed price with an ultimate completion date of September 30, 2026, and performance takes place in South Korea.

Quick answers

Who was awarded contract W81K0225FA113?

W81K0225FA113 was awarded to Quidelortho Sales Company, LLC by Defense Health Agency (Department of Defense) on October 1, 2025.

How much is contract W81K0225FA113 worth?

The government has obligated $147,760 on W81K0225FA113.

Is contract W81K0225FA113 an order under another contract?

Yes. W81K0225FA113 is a delivery order under W81K0224D0008, an indefinite delivery contract.

Was contract W81K0225FA113 competed?

The extent of competition for W81K0225FA113 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award